摘要
目的分析去乙酰毛花苷注射液和胺碘酮治疗急诊危重症合并快速心律失常的临床效果。方法选取2016年5月至2019年5月本院收治的80例急诊危重症合并快速心律失常患者,采取随机数字表法分为两组,各40例。对照组接受去乙酰毛花苷注射液治疗,观察组接受胺碘酮治疗。比较两组患者心功能指标及不良反应发生率。结果观察组心功能指标中的E峰、E/A比值均高于对照组,A峰、LVEF、LVEDD均高于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率为15.00%,明显低于对照组,差异有统计学意义(P<0.05)。结论去乙酰毛花苷注射液和胺碘酮均可改善急诊危重症合并快速心律失常患者病情症状,但胺碘酮临床效果更佳,且不良反应少,值得临床推广。
Objective To analyze the clinical effect of cedilanid and amiodarone in the treatment of acute critical patients with tachyarrhythmia.Methods 80 patients with acute critical illness and tachyarrhythmia in our hospital from May 2016 to May 2019 were collected and divided into two groups by random number table,with 40 cases in each group.The control group received cedilanid treatment and the observation group received amiodarone treatment.The cardiac function indexes and the occurrence of no reaction were compared between the two groups.Results The e peak and E/A ratio in the observation group were higher than those in the control group,and the A peak,LVEF and LVEDd in the observation group were higher than those in the control group(P<0.05).The incidence of adverse reactions in the observation group was 15.00%,which was significantly lower than that in the control group(P<0.05).Conclusion Both cedilanid and amiodarone can improve the symptoms of emergency critical patients with tachyarrhythmia,but amiodarone has better clinical effect and fewer adverse reactions,which is worthy of clinical promotion.
作者
兆欣
高兴
李德伟
Zhao Xin;Gao Xing;Li Dewei(Department of Social Emergency,Shenyang Emergency Center,Shenyang,Liaoning,110006,China)
出处
《当代医学》
2020年第36期17-18,共2页
Contemporary Medicine
